Johnson & Johnson vaccine: EU regulator says blood clot very rare side effect

The EU’s drugs regulator has said that blood clots should be listed as a “very rare” side effect of the Johnson & Johnson Covid-19 vaccine.

The European Medicines Agency said in a statement that it had found a “possible link” between the jab and clots.

But it added that the benefits of the Covid-19 vaccine outweighed the risks.

Out of more than seven million people who have received the jab in the US, eight people developed rare blood clots, including one person who died.

Earlier this month, the EMA made the same recommendation for the Covid-19 vaccine produced by Oxford-AstraZeneca.

That recommendation, made on 7 April, came after 86 out of 25 million Europeans administered with the jab developed the unusual blood clots.

The UK then stopped administering the AstraZeneca vaccine to people under 30 years old.

Read the full article at: BBC